Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Third Harmonic Bio Inc THRD

Healthcare
Third Harmonic Bio, Inc. is a biopharmaceutical company. The Company is focused on advancing the next wave of medicine for inflammatory diseases through the development of novel, small-molecule inhibitors of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. It is developing medicine for the treatment of inflammatory diseases, including dermal... see more

Recent & Breaking News (NDAQ:THRD)

Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference

GlobeNewswire 6 hours ago

Third Harmonic Bio to Participate in Upcoming Investor Conferences in November

GlobeNewswire November 7, 2024

Third Harmonic Bio Announces Third Quarter 2024 Financial Results

GlobeNewswire November 7, 2024

Third Harmonic Bio to Participate in Upcoming Investor Conferences in September

GlobeNewswire September 10, 2024

Third Harmonic Bio to Participate in Upcoming Investor Conferences

GlobeNewswire August 26, 2024

Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire August 8, 2024

Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference

GlobeNewswire May 28, 2024

Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire May 15, 2024

Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors

GlobeNewswire March 28, 2024

Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire March 26, 2024

Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference

GlobeNewswire February 26, 2024

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Third Harmonic Bio, Inc. (NASDAQ: THRD)

PR Newswire February 22, 2024

Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update

GlobeNewswire January 4, 2024

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Third Harmonic Bio, Inc. (NASDAQ: THRD)

PR Newswire November 9, 2023

Third Harmonic Bio Announces Third Quarter 2023 Financial Results

GlobeNewswire November 9, 2023

Third Harmonic Bio Announces Leadership Changes

GlobeNewswire October 31, 2023

Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference

GlobeNewswire August 31, 2023

Third Harmonic Bio Announces Second Quarter 2023 Financial Results

GlobeNewswire August 10, 2023

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Third Harmonic Bio, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

PR Newswire August 1, 2023

Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335

GlobeNewswire July 25, 2023